We are excited to announce the expansion of our peptide synthesis capabilities with a new high-throughput synthesis platform, enabling us to handle larger peptide library…
Read MoreThe Reproducibility Crisis in Antibody-Based Research A series of high-profile analyses have quantified the scope of the antibody reproducibility problem: Bhatt et al. estimated that…
Read MoreHistorical Context and Research Foundations The concept of short peptide bioregulators emerged from the pioneering work of Vladimir Khavinson at the Saint Petersburg Institute of…
Read MoreCritical Variables in Cytokine-Driven Differentiation Directed differentiation of human pluripotent stem cells (hPSCs) — both embryonic (hESCs) and induced (hiPSCs) — relies on the precise…
Read MoreThe Renaissance of Macrocyclic Therapeutics Cyclic peptides occupy a unique chemical space — larger than traditional small molecules (MW < 500 Da, Lipinski rule-of-five compliant)…
Read MoreThe Undruggable Proteome and the α-Helix Solution An estimated 80% of disease-relevant protein-protein interactions (PPIs) remain inaccessible to conventional small molecule therapeutics (Verdine & Walensky,…
Read MorePeptide Synthesis Technology Overview Modern solid-phase peptide synthesis (SPPS), pioneered by R. Bruce Merrifield (Nobel Prize, 1984), remains the gold standard for custom peptide production.…
Read MoreThe Protein Folding Problem in Recombinant Production The choice of expression system fundamentally determines the structural integrity — and therefore the biological activity — of…
Read More